-
effectivehealthcare.ahrq.gov/sites/default/files/s96.pdf
October 01, 2007 - ORIGINAL ARTICLE
Evaluation and Overview of the National Electronic Injury
Surveillance System-Cooperative Adverse Drug Event
Surveillance Project (NEISS-CADES)
Michael A. Jhung, MD, MPH,* Daniel S. Budnitz, MD, MPH,* Aaron B. Mendelsohn, PhD,*†
Kelly N. Weidenbach, MPH,* Theresa D. Nelson, MS,‡ and Daniel A. Polloc…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-196-evidence-summary-immunotherapy-asthma.pdf
March 01, 2018 - The Role of Immunotherapy in the Treatment of Asthma--Evidence Summary
Comparative Effectiveness Review
Number 196
The Role of Immunotherapy in the Treatment of Asthma
Evidence Summary
Background
Asthma is a chronic inflammatory
disorder of the airways, characterized by
varying degrees of airflow obstruction…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/dcis-mri-utilization_research.pdf
August 01, 2012 - Data Points 13: Use of Preoperative Breast MRI among older women with ductal carcinoma in situ and locally invasive breast cancer
Use of Preoperative Breast MRI Data Points # 13
Use of preoperative MRI among older women with ductal carcinoma in
situ and locally invasive breast cancer
Rates of MRI use prior to surg…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/evidence-examples_white-paper.pdf
April 01, 2014 - Template for Reports Developed
Research White Paper
Observational Evidence and Strength of Evidence
Domains: Case Examples
Research White Paper
Observational Evidence and Strength of Evidence
Domains: Case Examples
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and …
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/dcis-endocrine-therapy_research.pdf
August 01, 2012 - Data Points 14: Use of Endocrine Therapy
Use of Endocrine Therapy Data Points # 14
Use of endocrine therapy following diagnosis of ductal carcinoma in
situ or early invasive breast cancer
Women with ductal carcinoma in situ
(DCIS) were more likely to be treated with
tamoxifen than an aromatase inhibitor (AI).
F…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-surveillance_executive.pdf
December 01, 2011 - 04-E029-1 Summary
Advancing Excellence in Health Care • www.ahrq.gov
Agency for Healthcare Research and Quality Evidence-Based
Practice
Backgrounda
In 2011, more than 240,000 men are projected
to be diagnosed with prostate cancer, and
33,000 are projected to die from the disease in
the United States. In the United…
-
effectivehealthcare.ahrq.gov/sites/default/files/Evidence%20Summary_0.pdf
April 01, 2020 - Treatment of Depression in Children and Adolescents: A Systematic Review - Evidence Summary
Purpose of Review
The purpose of the review is to examine the benefits
and harms of pharmacological and nonpharmacological
treatments for child and adolescent depressive disorders.
Key Messages
• Cognitive behavioral t…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/Evidence%20Summary_0_0.pdf
April 01, 2020 - Treatment of Depression in Children and Adolescents: A Systematic Review - Evidence Summary
Purpose of Review
The purpose of the review is to examine the benefits
and harms of pharmacological and nonpharmacological
treatments for child and adolescent depressive disorders.
Key Messages
• Cognitive behavioral t…
-
effectivehealthcare.ahrq.gov/products/vaccine-safety/research
July 01, 2014 - Current Page Topic Timeline Aug. 31, 2012 Topic Initiated Oct. 22, 2012 Research Protocol Jul. 1, 2014 Systematic Review Oct. 8, 2014 Disposition of Comments Report Safety of Vaccines Used for Routine Immunization in the United States
Systematic Review Archived July 1, 2014 Web Version [NLM Site] Download Main Doc…
-
effectivehealthcare.ahrq.gov/products/hemorrhage-postpartum/research-protocol
June 11, 2014 - Current Page Topic Timeline Mar. 14, 2013 Topic Suggestion Jun. 11, 2014 Research Protocol Apr. 28, 2015 Systematic Review Oct. 9, 2015 Disposition of Comments Report Management of Postpartum Hemorrhage
Research Protocol Archived June 11, 2014 Download Main Document PDF 449 KB
Archived: This report i…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-immunotherapy-2011_research.pdf
January 01, 2011 - Methods Research Report
Development of Quality Criteria To Evaluate
Nontherapeutic Studies of Incidence, Prevalence, or
Risk Factors of Chronic Diseases: Pilot Study of New
Checklists
This report is based on research conducted by the Minnesota Evidence-based Practice Center
und…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-2007_research-2007-1.pdf
January 01, 2007 - Microsoft Word - Comp Eff 10.doc
This report is based on research conducted by the Duke Evidence-based Practice Center
(EPC) under contract to the Agency for Healthcare Research and Quality (AHRQ), Rockville,
MD (Contract No. 290-02-0025). The findings and conclusions in this do…
-
effectivehealthcare.ahrq.gov/products/prostate-cancer-therapies-update/research-protocol
March 29, 2013 - Current Page Topic Timeline Mar. 23, 2013 Topic Initiated Mar. 29, 2013 Research Protocol Dec. 16, 2014 Systematic Review Apr. 16, 2015 Disposition of Comments Report Comparative Effectiveness of Therapies for Clinically Localized Prostate Cancer: An Update of a 2008 Comparative Effectiveness Review
Research Protoc…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/c-diff-infections_executive.pdf
December 01, 2011 - Layout 1
Introduction
Clostridium difficile infection (CDI) is a
serious healthcare-associated infection and
a growing health care problem. C. difficile
is a Gram-positive, spore-forming,
anaerobic bacterium that, when ingested,
can cause CDI if it is a toxigenic strain.
CDI symptoms include varying levels of
diarrh…
-
effectivehealthcare.ahrq.gov/products/renal-update/research-protocol
January 20, 2015 - Current Page Topic Timeline Jan. 15, 2015 Topic Initiated Jan. 20, 2015 Research Protocol Aug. 16, 2016 Systematic Review Dec. 20, 2016 Disposition of Comments Report Renal Artery Stenosis Update
Research Protocol Archived January 20, 2015 Download Main Document PDF 467.8 KB
Archived: This report is …
-
effectivehealthcare.ahrq.gov/sites/default/files/s23.pdf
October 01, 2007 - ORIGINAL ARTICLE
Improving Depiction of Benefits and Harms
Analyses of Studies of Well-Known Therapeutics and Review of
High-Impact Medical Journals
Artyom Sedrakyan, MD, PhD,*†‡ and Chuck Shih, MHS*
Abstract: The issues of weighing benefits and harms and of shared
decision-making have become increasingly important…
-
effectivehealthcare.ahrq.gov/products/c-diff-infections/research-protocol
May 24, 2010 - Current Page Topic Timeline Mar. 10, 2008 Topic Suggestion May. 24, 2010 Research Protocol Dec. 19, 2011 Systematic Review May. 2, 2012 Disposition of Comments Report Sep. 25, 2014 Surveillance Report Effectiveness of Screening and Treatment of C. difficile Infections
Research Protocol Archived May 24, 2010 Downlo…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-artery-stenosis_research-2007.pdf
January 01, 2007 - Microsoft Word - finbody.doc
This report is based on research conducted by the Tufts-New England Medical Center
Evidence-based Practice Center (EPC) under contract to the Agency for Healthcare Research
and Quality (AHRQ), Rockville, MD (Contract No. 290-02-0022). The findings and
conclusions in this d…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breastfeeding-health-outcomes-protocol.pdf
February 01, 2023 - Breastfeeding and Health Outcomes for Infants and Children
Evidence-based Practice Center Systematic Review Protocol
Project Title: Breastfeeding and Health Outcomes for Infants and Children
I. Background and Objectives for the Systematic Review
Breastfeeding – the feeding of human milk at the breast or exp…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-screening_executive.pdf
April 01, 2012 - 1
Comparative Effectiveness Review
Number 59
Screening for Glaucoma:
Comparative Effectiveness
Executive Summary
Background
Glaucoma is a leading cause of visual
impairment and blindness and affects
approximately 60.5 million people
worldwide.1,2 Although glaucoma may
be characterized by optic nerve damage, …